
Decreasing statin copayments because of the patent expiration of simvastatin has led to moderate increases in therapy adherence.
Decreasing statin copayments because of the patent expiration of simvastatin has led to moderate increases in therapy adherence.
Published: December 1st 2008 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.